Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)
Carcinoma in Situ (Phase 3)
Cervical Intraepithelial Neoplasia (Phase 3)
Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (1 total)